| PACKAGING TYPE: | 10x15 Blister (10 Strips In 1 Box) |
| COMPOSITION: | Glimepiride 2mg+metformin 500mg(sr)+voglibose 0.2mg |
| FORMULATION: | Tablet |
| Description: | MEPRIMET MV2 Tablet is a triple-combination antidiabetic medication containing: Glimepiride 2mg – a sulfonylurea that stimulates insulin secretion from pancreatic beta cells. Metformin (SR) 500mg – a biguanide that reduces hepatic glucose production and improves insulin sensitivity, with sustained-release action for prolonged control. Voglibose 0.2mg – an alpha-glucosidase inhibitor that delays carbohydrate absorption in the intestine, helping control post-meal blood sugar spikes. This formulation is used for the management of Type 2 Diabetes Mellitus, especially in patients requiring intensive triple therapy. It offers comprehensive glycemic control by managing both fasting and postprandial blood glucose levels. |
| Side Effects: | Common side effects: Flatulence or abdominal discomfort (due to Voglibose) Nausea or diarrhea Headache Hypoglycemia Rare but serious side effects: Severe hypoglycemia Liver function abnormalities Allergic reactions (rash, swelling, difficulty breathing) |
| How to Use: | Take MEPRIMET MV2 Tablet orally, usually once daily with meals or as prescribed. Take preferably just before or with the first bite of a meal. Swallow the tablet whole; do not crush or chew (SR formulation). Do not skip meals to prevent hypoglycemia. Monitor blood glucose levels regularly. |
| Precaution: | Monitor for symptoms of hypoglycemia (sweating, dizziness, confusion). Use cautiously in patients with kidney or liver impairment. Avoid excessive alcohol consumption. Inform your doctor about all medications to avoid interactions. Not recommended during pregnancy or breastfeeding without medical advice. |
| Product Benefits: | Provides triple-action blood sugar control. Reduces postprandial (after-meal) glucose spikes. Improves insulin secretion and insulin sensitivity. Sustained-release Metformin ensures prolonged glucose control. Suitable for patients needing stronger gly |
Frequently Asked Questions
It is used to manage Type 2 Diabetes Mellitus with triple-drug therapy.
Yes, it contains a higher dose of Glimepiride (2mg) for stronger glycemic control.
Voglibose helps control post-meal blood sugar spikes by slowing carbohydrate absorption.














